Medigus Ltd (Israel) Performance

MDGS -- Israel Stock  

ILS 56.90  0.70  1.22%

Medigus Ltd has performance score of 1 on a scale of 0 to 100. The company secures Beta (Market Risk) of 0.6721 which conveys that as returns on market increase, Medigus Ltd returns are expected to increase less than the market. However during bear market, the loss on holding Medigus Ltd will be expected to be smaller as well.. Although it is extremely important to respect Medigus Ltd price patterns, it is better to be realistic regarding the information on equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Medigus Ltd technical indicators you can presently evaluate if the expected return of 0.1259% will be sustainable into the future. Medigus Ltd right now secures a risk of 5.3714%. Please verify Medigus Ltd Coefficient Of Variation, Variance and the relationship between Downside Deviation and Standard Deviation to decide if Medigus Ltd will be following its current price movements.
Horizon     30 Days    Login   to change

Medigus Ltd Relative Risk vs. Return Landscape

If you would invest  5,690  in Medigus Ltd on September 22, 2018 and sell it today you would earn a total of  0.00  from holding Medigus Ltd or generate 0.0% return on investment over 30 days. Medigus Ltd is generating 0.1259% of daily returns and assumes 5.3714% volatility on return distribution over the 30 days horizon. Simply put, 48% of equities are less volatile than Medigus Ltd and 98% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Medigus Ltd is expected to generate 5.06 times more return on investment than the market. However, the company is 5.06 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The DOW is currently generating roughly -0.21 per unit of risk.

Medigus Ltd Market Risk Analysis

Sharpe Ratio = 0.0234
Good Returns
Average Returns
Small Returns
Negative Returns

Medigus Ltd Relative Performance Indicators

Estimated Market Risk
  actual daily
 52 %
of total potential
Expected Return
  actual daily
 2 %
of total potential
Risk-Adjusted Return
  actual daily
 1 %
of total potential
Based on monthly moving average Medigus Ltd is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medigus Ltd by adding it to a well-diversified portfolio.

Medigus Ltd Performance Rating

Medigus Ltd Risk Adjusted Performance Analysis


Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Medigus Ltd are ranked lower than 1 (%) of all global equities and portfolios over the last 30 days.

Medigus Ltd Alerts

Equity Alerts and Improvement Suggestions

Medigus Ltd has very high historical volatility over the last 30 days
Medigus Ltd has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 420 K. Net Loss for the year was (1.61 M) with loss before overhead, payroll, taxes, and interest of (49 K).
MEDIGUS has accumulated about 5.02 M in cash with (4.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Please see also Stocks Correlation. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.